NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016

Go back to NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016
NEOGENOMICS (NASDAQ: NEO) Delayed: 19.91 +0.02 (0.10%)
Previous Close $19.89    52 Week High $9.54 
Open $19.91    52 Week Low $5.49 
Day High $20.03    P/E 497.75 
Day Low $19.40    EPS $0.04 
Volume 4,400,263